查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1540906

2024-2032 年按测试方法、产品、技术、应用、最终用户和地区分類的血液培养测试市场报告

Blood Culture Test Market Report by Testing Method, Product, Technology, Application, End User, and Region 2024-2032
出版日期: | 出版商: IMARC | 英文 148 Pages | 商品交期: 2-3个工作天内

价格

2023年全球血液培养测试IMARC Group规模达51亿美元。个人细菌和真菌感染发病率的上升、医院获得性感染（HAIs）盛行率的增加以及诊断技术的不断进步是推动市场成长的一些主要因素。

全球血液培养测试市场分析：

主要市场驱动因素：败血症、血液感染和细菌感染等传染病的日益普及是市场成长的主要动力。除此之外，对准确诊断方法的需求不断增长也导致越来越多地采用血液培养测试来识别这些感染的病原体。这指导医生开出适当的治疗方法并降低死亡率。

主要市场趋势：自动化系统、分子诊断和快速检测方法等血液培养检测技术的不断进步正在提高这些检测的准确性和效率，这是市场成长的主要关键趋势。

地理趋势：根据报告，北美占据最大的市场份额。该地区的成长是由不断增长的医疗基础设施推动的，其中包括众多的医院、诊所和实验室网路。此外，该地区完善的医疗保险体係也促进了该地区的成长。

竞争格局：血液培养测试市场的一些领导者包括 Abbott Laboratories、Danaher Corporation、Becton、Dickinson and Company、bioMeriux SA、Bruker Corporation、Luminex Corporation、Merck KGaA、Siemens Healthcare GmbH、F.Hoffmann-La Roche Ltd.、T2生物系统公司、赛默飞世尔科技公司等。

挑战与机会：血液培养检测市场的突出挑战之一是品质控制和标准化。确保不同实验室和地区保持一致的品质和标准化具有挑战性。然而，许多公司正在开发和实施自动化血液培养系统和标准化设备。自动化减少了处理和处理样品过程中的人为错误和变异性。标准化设备确保不同测试地点使用一致的条件和协议。预计这将增加来年的血液培养测试市场份额。

血液培养测试市场趋势：

细菌和真菌感染的发生率不断上升

细菌和真菌感染数量的不断增加以及老年人口的增加主要推动了血液培养测试市场的成长。根据欧洲疾病预防与控制中心2023年1月的出版物，截至2022年12月31日，已报告登革热病例4,110,465例，死亡4,099例。因此，与严重登革热相关的疾病进展的早期发现增强了对血液检测以及时诊断疾病的需求，从而推动了市场的发展。及早发现与严重登革热相关的疾病进展并获得适当的医疗护理可以将严重登革热的死亡率降低至 1% 以下。此外，各个主要市场参与者正在推出先进的诊断解决方案，以应对不断增加的诊断数量。例如，根据2022 年5 月发表在《Scientific Reports》上的研究文章，基于5,333 名患有各种细菌的患者和160 名患有COVID-19 的患者的常规血液检测，构建了一个用于COVID- 19 诊断的机器学习模型，并进行了交叉验证。此类用于处理不断升级的细菌和真菌感染病例的创新预计将在未来几年促进血液培养测试市场的成长。

院内感染 (HAI) 的盛行率不断上升

HAI 是患者在医疗机构内接受其他疾病治疗时所发生的感染。住院患者数量的增加导致 HIA 病例不断增加，这反过来又提振了血液培养检测市场。此外，据世界卫生组织称，每年进行近 2.35 亿例大型外科手术。美国疾病管制与预防中心发布的《2020年医疗保健相关感染进展报告》显示，2020年美国报告了近18,416例手术部位感染。报告也通报，其中 6,094 例感染发生在结肠手术期间，2,173 例感染发生在髋关节置换术期间。院内感染的激增促使人们需要进行强而有力的血液培养检测。此外，血液培养检查对于诊断和监测传染病至关重要，因此随着医院感染率的不断上升，对这些测试的需求也随之增加。

诊断技术的新兴进步

越来越多地采用自动化血液培养系统，该系统使用先进的边缘感测器和软体演算法比传统方法更快、更精确地检测血液样本中的微生物生长，这是市场的另一个重要成长诱导因素。各主要市场参与者正在广泛投资于研发活动，以引入强大的自动化血液检测技术。例如，2022年12月，InsilicoMedicine推出了Life Star，这是第六代智慧机器人药物发现实验室。全自动人工智慧机器人实验室执行标靶发现、精准医学开发、化合物筛选和转化研究。同样，2023年6月，太阳药业宣布增加对特种药和仿製药业务的研发投入。据该公司称，其目前在美国市场的仿製药管道包括97个ANDA，还有13个新药申请正在等待美国FDA的批准。除此之外，各相关监管机构也正在采取措施加强诊断，这为整体市场创造了积极的前景。例如，医疗保险和医疗补助服务中心(CMS) 是北美的一个监管机构，透过临床实验室改进修正案(CLIA) 监控和监管在美国对人体进行的所有实验室检测，其中包括260,000 个实验室实体。除此之外，将人工智慧 (AI) 和机器学习 (ML) 演算法整合到血液培养分析中，可以快速分析大量资料集并预测结果。这反过来又有助于医疗保健专业人员做出明智的决定。

目录

第一章：前言

第 2 章：范围与方法

  • 研究目的
  • 利害关係人
  • 数据来源
    • 主要来源
    • 二手资料
  • 市场预测
    • 自下而上的方法
    • 自上而下的方法
  • 预测方法

第 3 章：执行摘要

第 4 章：简介

  • 概述
  • 主要行业趋势

第 5 章：全球血液培养测试市场

  • 市场概况
  • 市场表现
  • COVID-19 的影响
  • 市场预测

第 6 章：市场区隔：透过测试方法

  • 传统的
    • 市场趋势
    • 市场预测
  • 自动化
    • 市场趋势
    • 市场预测

第 7 章：市场区隔：依产品

  • 耗材
    • 市场趋势
    • 主要类型
      • 血液培养介质
        • 有氧血培养基
        • 厌氧血培养基
        • 真菌/酵母血培养基
        • 分枝桿菌血培养基
      • 检测试剂盒和试剂
      • 血液培养配件
    • 市场预测
  • 仪器仪表
    • 市场趋势
    • 主要类型
      • 自动化血液培养系统
      • 配套实验室设备
        • 孵化器
        • 菌落计数器
        • 显微镜
        • 革兰氏染色仪
    • 市场预测
  • 软体和服务
    • 市场趋势
    • 市场预测

第 8 章：市场区隔：依技术

  • 基于文化的技术
    • 市场趋势
    • 市场预测
  • 分子技术
    • 市场趋势
    • 主要类型
      • 微阵列
      • 聚合酶炼式反应
      • 萤光原位杂交
    • 市场预测
  • 蛋白质体技术
    • 市场趋势
    • 市场预测
  • 其他的
    • 市场趋势
    • 市场预测

第 9 章：市场区隔：按应用

  • 细菌感染
    • 市场趋势
    • 市场预测
  • 霉菌感染
    • 市场趋势
    • 市场预测
  • 分枝桿菌感染
    • 市场趋势
    • 市场预测

第 10 章：市场区隔：依最终用户

  • 医院实验室
    • 市场趋势
    • 市场预测
  • 参考实验室
    • 市场趋势
    • 市场预测
  • 研究实验室
    • 市场趋势
    • 市场预测
  • 其他的
    • 市场趋势
    • 市场预测

第 11 章：市场区隔：按地区

  • 北美洲
    • 美国
    • 加拿大
  • 亚太地区
    • 中国
    • 日本
    • 印度
    • 韩国
    • 澳洲
    • 印尼
    • 其他的
  • 欧洲
    • 德国
    • 法国
    • 英国
    • 义大利
    • 西班牙
    • 俄罗斯
    • 其他的
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 其他的
  • 中东和非洲
    • 市场趋势
    • 市场细分：按国家/地区
    • 市场预测

第 12 章：SWOT 分析

  • 概述
  • 优势
  • 弱点
  • 机会
  • 威胁

第 13 章：价值链分析

第 14 章：波特五力分析

  • 概述
  • 买家的议价能力
  • 供应商的议价能力
  • 竞争程度
  • 新进入者的威胁
  • 替代品的威胁

第15章：竞争格局

  • 市场结构
  • 关键参与者
  • 关键参与者简介
    • Abbott Laboratories
    • Danaher Corporation
    • Becton, Dickinson and Company
    • bioMeriux SA
    • Bruker Corporation
    • Luminex Corporation
    • Merck KGaA
    • Siemens Healthcare GmbH
    • F.Hoffmann-La Roche Ltd
    • T2 Biosystems Inc
    • Thermo Fisher Scientific Company
Product Code: SR112024A2275

The global blood culture test market size reached US$ 5.1 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 9.9 Billion by 2032, exhibiting a growth rate (CAGR) of 7.5% during 2024-2032. The rising incidences of bacterial and fungal infections among individuals, the increasing prevalence of hospital-acquired infections (HAIs), and the emerging advancements in diagnostic technology are some of the major factors contributing to the market growth.

Global Blood Culture Test Market Analysis:

Major Market Drivers: The increasing prevalence of infectious diseases such as sepsis, bloodstream infections, and bacterial infections is primarily driving the market growth. In addition to this, the rising demand for accurate diagnostic methods is also leading to the increased adoption of blood culture tests to identify the causative agents of these infections. This guides physicians in prescribing appropriate treatments and reducing mortality rates.

Key Market Trends: Ongoing advancements in blood culture testing technologies, such as automated systems, molecular diagnostics, and rapid detection methods, are enhancing the accuracy and efficiency of these tests, which is acting as a primary key trend for the market growth.

Geographical Trends: According to the report, North America accounted for the largest market share. The growth in this region is driven by the growing healthcare infrastructure that includes numerous networks of hospitals, clinics, and laboratories. Furthermore, the presence of a well-established healthcare insurance system in the region is also contributing to the region's growth.

Competitive Landscape: Some of the blood culture test market leaders are Abbott Laboratories, Danaher Corporation, Becton, Dickinson and Company, bioMeriux SA, Bruker Corporation, Luminex Corporation, Merck KGaA, Siemens Healthcare GmbH, F.Hoffmann-La Roche Ltd., T2 Biosystems Inc., Thermo Fisher Scientific Company, among others.

Challenges and Opportunities: One of the prominent challenges in the blood culture test market is quality control and standardization. Ensuring consistent quality and standardization across different laboratories and regions is challenging. However, many companies are developing and implementing automated blood culture systems and standardized equipment. Automation reduces human error and variability in handling and processing samples. Standardized equipment ensures consistent conditions and protocols are used across different testing sites. This in turn is anticipated to augment the blood culture test market share in the coming year.

Blood Culture Test Market Trends:

The Rising Incidences of Bacterial and Fungal Infections

The escalating number of bacterial and fungal infections and a growing geriatric population are primarily driving the growth of the blood culture test market. According to the European Centre for Disease Prevention and Control's January 2023 publication, up to December 31, 2022, 4,110,465 cases of dengue and 4,099 deaths were reported. As a result, early detection of disease progression associated with severe dengue is bolstering the demand for blood testing for timely diagnosis of the diseases, thus driving the market. Early detection of disease progression associated with severe dengue and access to proper medical care can lower fatality rates of severe dengue to below 1%. Furthermore, various key market players are introducing advanced diagnostic solutions to tackle the bolstering number of diagnoses. For instance, according to the study article published in May 2022 in Scientific Reports, a machine learning model was constructed for COVID-19 diagnosis based and cross-validated on the routine blood test of 5,333 patients with various bacterial and 160 patients having COVID-19 infections. Such innovations to handle the escalating cases of bacterial and fungal infections are anticipated to catalyze blood culture test market growth in the coming years.

The Increasing Prevalence of Hospital-Acquired Infections (HAIs)

HAIs are infections that patients acquire while receiving treatment for other conditions within healthcare facilities. The increasing numbers of patients in hospital stays are leading to escalating cases of HIAs, which in turn is bolstering the market for blood culture tests. Additionally, according to the WHO, nearly 235 million major surgical procedures are performed every year. The Centers for Disease Control and Prevention issued a Healthcare Associated Infection Progress Report 2020, which indicated that there were nearly 18,416 surgical site infections reported in 2020 in the United States. It also reported that out of this, 6,094 infections were during colon surgery, and 2,173 occurred during hip arthroplasty. Such a surge in hospital-acquired infections is catalyzing the need for robust blood culture tests. Moreover, blood culture tests are essential in diagnosing and monitoring infectious diseases, thus escalating the demand for these tests with the growing number of HAI rates.

The Emerging Advancements in Diagnostic Technology

The increasing adoption of automated blood culture systems, which use advanced edge sensors and software algorithms to detect microbial growth in blood samples more rapidly and precisely than traditional methods, is acting as another significant growth-inducing factor for the market. Various key market players are extensively investing in research and development activities to introduce robust automated blood testing technologies. For instance, in December 2022, InsilicoMedicine launched Life Star, which was the 6th generation Intelligent Robotics Drug Discovery Laboratory. The fully automated AI-powered robotics laboratory performs target discovery, precision medicine development, compound screening, and translational research. Similarly, in June 2023, Sun Pharmaceutical Industries announced an increase in R&D investment in specialty and generics businesses. According to the firm, its current generics pipeline for the US market includes 97 ANDAs, while 13 new drug applications are awaiting the U.S. FDA's approval. In addition to this, various concerned regulatory authorities are also taking initiatives to enhance diagnostics, which is creating a positive outlook for the overall market. For instance, the Centers for Medicare & Medicaid Services (CMS) is a regulatory body in North America that monitors and regulates all laboratory testing performed on humans in the U.S. through the Clinical Laboratory Improvement Amendments (CLIA), which includes 260,000 laboratory entities. Besides this, the integration of artificial intelligence (AI) and machine learning (ML) algorithms into blood culture analysis is enabling a quick analysis of vast datasets and predicting outcomes. This, in turn, assists healthcare professionals in making informed decisions.

Blood Culture Test Industry Segmentation:

IMARC Group provides an analysis of the key trends in each segment of the global blood culture test market report, along with forecasts at the global, regional, and country levels for 2024-2032. Our report has categorized the market based on testing method, product, technology, application, and end user.

Breakup by Testing Method:

Conventional

Automated

Conventional testing represents the most popular method used

The report has provided a detailed breakup and analysis of the market based on the testing method. This includes conventional and automated. According to the report, conventional testing accounted for the largest market share.

Conventional tests are employed in hospitals, clinics, and healthcare facilities across the globe. They serve as a fundamental diagnostic tool to identify the presence of bacteria, fungi, or other microorganisms in the bloodstream of the patient. Moreover, as these tests are essential for physicians to identify the appropriate course of treatment, various key market players are launching technologically advanced blood tests. For instance, in January 2022, Eurofins subsidiary empowerDX launched PFAS Exposure in the United States, a direct-to-consumer at-home test to determine levels of per- and polyfluorinated alkyl substances (PFAS) in a person's blood and measure 47 of the PFAS chemical compounds. Besides this, conventional tests are reliable, providing healthcare professionals with a well-established and trusted method for detecting bloodstream infections. This level of reliability is augmenting the demand for conventional tests.

Breakup by Product:

Consumables

Blood Culture Media

Aerobic Blood Culture Media

Anaerobic Blood Culture Media

Fungi/Yeast Blood Culture Media

Mycobacteria Blood Culture Media

Assay Kits and Reagents

Blood Culture Accessories

Instruments

Automated Blood Culture Systems

Supporting Laboratory Equipment

Incubators

Colony Counters

Microscopes

Gram Stainers

Software and Services

Consumables presently account for the largest market share.

A detailed breakup and analysis of the market based on the product has also been provided in the report. This includes consumables [blood culture media (aerobic blood culture media, anaerobic blood culture media, fungi/yeast blood culture media, and mycobacteria blood culture media), assay kits and reagents, and blood culture accessories], instruments [automated blood culture systems, supporting laboratory equipment, (incubators, colony counters, microscopes, and gram stainers)], and software and services. According to the report, consumables accounted for the largest market share.

Consumables are employed at various essential junctures in the blood culture process. According to the American Cancer Society's 2022 statistics, there were approximately 1,918,030 new cases of cancer in the United States in 2022. Such an increasing burden of diseases such as cancer creates the need for precision medicine, which leads to the increase in demand for cell culture products and consumables for their development and hence drives the growth of the market. Moreover, various leading market players are increasingly focusing on research and development activities to develop improved cell culture products. For instance, in February 2022, KromaTiD launched a comprehensive suite of cell and blood culture growth, isolation, processing, and quality control services. The launch of such products and services by the companies also boosts the demand for cell culture products and consumables and is thus expected to drive the growth of this segment.

Breakup by Technology:

Culture-based Technology

Molecular Technology

Microarray

PCR

PNA-FISH

Proteomic Technology

Others

Culture-based technology holds the largest share of the market

A detailed breakup and analysis of the market based on the technology has also been provided in the report. This includes culture-based technology, molecular technology (microarray, PCR, PNA-FISH), proteomic technology, and others. According to the report, culture-based technology accounted for the largest market share.

Culture-based technology allows for the detection and identification of microbial pathogens, such as bacteria and fungi, in the blood samples of patients, which is essential in diagnosing bloodstream infections (BSIs) that can be life-threatening. As a result, various key companies are extensively investing in research activities to enhance culture-based technology. For instance, in June 2022, Evonik launched the cQrex portfolio of cell culture ingredients to increase efficiency and productivity in bioprocesses for producing monoclonal antibodies, vaccines, viral vectors, and therapeutic cells. Similarly, in February 2022, CellulaREvolution raised GBP 1.75 Million to accelerate the launch of its continuous cell culture technology. Furthermore, culture-based technology offers a high level of sensitivity. It can distinguish between several strains of microorganisms, allowing healthcare providers to customize their treatment strategies accordingly.

Breakup by Application:

Bacterial Infections

Fungal Infections

Mycobacterial Infections

Bacterial infections presently account for the largest market share

A detailed breakup and analysis of the market based on the application has also been provided in the report. This includes bacterial infections, fungal infections, and mycobacterial infections. According to the report, bacterial infections accounted for the largest market share.

Bacterial infections are a prevalent concern in the healthcare sector. These infections can manifest in various forms, from mild to severe, and often require timely and accurate diagnosis for effective treatment. As a result, various healthcare institutions and pharmaceutical companies are increasingly investing in robust blood culture testing solutions. For instance, in June 2022, Basilea Pharmaceutica Ltd announced positive topline results for the Phase III ERADICATE study, evaluating ceftobiprole in the treatment of adult patients with bacterial bloodstream infections caused by Staphylococcus aureus (SAB). Similarly, in May 2022, Nabriva Therapeutics PLC agreed to extend its exclusive agreement with subsidiaries of Merck & Co. Inc. to promote and distribute SIVEXTRO (tedizolid phosphate, an antibiotic of the oxazolidinone class used to treat acute bacterial skin and skin structure infections (ABSSSI)) in the United States through December 31, 2026. Furthermore, the continuous advancements in technology improved the sensitivity and specificity of these tests, making them more reliable in detecting bacterial infections accurately.

Breakup by End User:

Hospital Laboratories

Reference Laboratories

Research Laboratories

Others

Hospital laboratories hold the largest share of the market

A detailed breakup and analysis of the market based on the end user have also been provided in the report. This includes hospital laboratories, reference laboratories, research laboratories, and others. According to the report, hospital laboratories accounted for the largest market share.

Hospital laboratories are equipped with advanced technology and several resources, enabling them to conduct tests with a high degree of accuracy and efficiency. These laboratories often deliver more reliable results compared to other laboratories, due to which hospital laboratories are the go-to choice for healthcare professionals. Various healthcare facilities are investing in the establishment and expansion of advanced hospital laboratories. For instance, in September 2021, the Indian division of Roche Diagnostics launched the Cobas pure integrated solutions analyzer with an advanced system suitable for many labs and hospitals operating in the country.

Breakup by Region:

North America

United States

Canada

Europe

Germany

France

United Kingdom

Italy

Spain

Russia

Others

Asia Pacific

China

Japan

India

South Korea

Australia

Indonesia

Others

Latin America

Brazil

Mexico

Others

Middle East and Africa

North America exhibits a clear dominance in the market

The market research report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America accounted for the largest market share.

The North American market is driven by the growing healthcare infrastructure that includes numerous networks of hospitals, clinics, and laboratories. Furthermore, the presence of a well-established healthcare insurance system in the region, ensuring that a substantial portion of the population has access to medical services, including blood culture testing, is also contributing to the region's growth. Additionally, the launch of technologically advanced blood tests in the United States will also positively impact the market growth. For instance, in January 2022, Eurofins subsidiary empowerDX launched PFAS Exposure in the United States, the direct-to-consumer at-home test to determine levels of Per- and Polyfluorinated Alkyl Substances (PFAS) in a person's blood and measure 47 of the PFAS forever chemical compounds. In addition to this, in August 2021, Smart Meter launched the glucose monitor for managing gestational diabetes. It provides an easy and reliable way to test, monitor, and manage blood glucose levels, ensuring that all care providers have immediate access to testing results. Moreover, regulatory bodies in North America maintain rigorous standards for healthcare products and services, which instill confidence in tests, making them a preferred choice for healthcare professionals and patients.

Competitive Landscape:

The market research report has provided a comprehensive analysis of the competitive landscape in the market. Detailed profiles of all major companies have also been provided. Some of the blood culture test top companies include:

Abbott Laboratories

Danaher Corporation

Becton, Dickinson and Company

bioMeriux SA

Bruker Corporation

Luminex Corporation

Merck KGaA

Siemens Healthcare GmbH

F.Hoffmann-La Roche Ltd.

T2 Biosystems Inc.

Thermo Fisher Scientific Company

(Please note that this is only a partial list of the key players, and the complete list is provided in the report.)

Global Blood Culture Test Market News:

November 2023: In observance of World AMR Awareness Week (WAAW), Magnolia Medical Technologies, Inc., the inventors of the Steripath Initial Specimen Diversion Device (ISDD), is leading the way to show how important it is to use diagnostics wisely to fight against the danger of antimicrobial resistance (AMR).

March 2023: Brooks Automation US, LLC announced the acquisition of Aim Lab Automation Technologies Pty Ltd. to expand solutions within the lab automation segment. This acquisition further expanded Brooks' presence beyond drug discovery into the clinical diagnostics market. Moreover, Aim Lab, in collaboration with PreciseFlex, will provide a broader set of capabilities and an expanded global presence to its customers.

October 2022: BD (Becton, Dickinson, and Company), a leading global medical technology company, and Magnolia Medical Technologies, Inc., announced a co-exclusive commercial agreement aimed at helping U.S. hospitals reduce blood culture contamination to help improve testing accuracy and ultimately improve clinical outcomes.

Key Questions Answered in This Report

  • 1. What was the size of the global blood culture test market in 2023?
  • 2. What is the expected growth rate of the global blood culture test market during 2024-2032?
  • 3. What are the key factors driving the global blood culture test market?
  • 4. What has been the impact of COVID-19 on the global blood culture test market?
  • 5. What is the breakup of the global blood culture test market based on the testing method?
  • 6. What is the breakup of the global blood culture test market based on the product?
  • 7. What is the breakup of the global blood culture test market based on technology?
  • 8. What is the breakup of the global blood culture test market based on the application?
  • 9. What is the breakup of the global blood culture test market based on the end user?
  • 10. What are the key regions in the global blood culture test market?
  • 11. Who are the key players/companies in the global blood culture test market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Blood Culture Test Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Testing Method

  • 6.1 Conventional
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Automated
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast

7 Market Breakup by Product

  • 7.1 Consumables
    • 7.1.1 Market Trends
    • 7.1.2 Major Types
      • 7.1.2.1 Blood Culture Media
        • 7.1.2.1.1 Aerobic Blood Culture Media
        • 7.1.2.1.2 Anaerobic Blood Culture Media
        • 7.1.2.1.3 Fungi/Yeast Blood Culture Media
        • 7.1.2.1.4 Mycobacteria Blood Culture Media
      • 7.1.2.2 Assay Kits and Reagents
      • 7.1.2.3 Blood Culture Accessories
    • 7.1.3 Market Forecast
  • 7.2 Instruments
    • 7.2.1 Market Trends
    • 7.2.2 Major Types
      • 7.2.2.1 Automated Blood Culture Systems
      • 7.2.2.2 Supporting Laboratory Equipment
        • 7.2.2.2.1 Incubators
        • 7.2.2.2.2 Colony Counters
        • 7.2.2.2.3 Microscopes
        • 7.2.2.2.4 Gram Stainers
    • 7.2.3 Market Forecast
  • 7.3 Software and Services
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast

8 Market Breakup by Technology

  • 8.1 Culture-based Technology
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Molecular Technology
    • 8.2.1 Market Trends
    • 8.2.2 Major Types
      • 8.2.2.1 Microarray
      • 8.2.2.2 PCR
      • 8.2.2.3 PNA-FISH
    • 8.2.3 Market Forecast
  • 8.3 Proteomic Technology
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast
  • 8.4 Others
    • 8.4.1 Market Trends
    • 8.4.2 Market Forecast

9 Market Breakup by Application

  • 9.1 Bacterial Infections
    • 9.1.1 Market Trends
    • 9.1.2 Market Forecast
  • 9.2 Fungal Infections
    • 9.2.1 Market Trends
    • 9.2.2 Market Forecast
  • 9.3 Mycobacterial Infections
    • 9.3.1 Market Trends
    • 9.3.2 Market Forecast

10 Market Breakup by End-User

  • 10.1 Hospital Laboratories
    • 10.1.1 Market Trends
    • 10.1.2 Market Forecast
  • 10.2 Reference Laboratories
    • 10.2.1 Market Trends
    • 10.2.2 Market Forecast
  • 10.3 Research Laboratories
    • 10.3.1 Market Trends
    • 10.3.2 Market Forecast
  • 10.4 Others
    • 10.4.1 Market Trends
    • 10.4.2 Market Forecast

11 Market Breakup by Region

  • 11.1 North America
    • 11.1.1 United States
      • 11.1.1.1 Market Trends
      • 11.1.1.2 Market Forecast
    • 11.1.2 Canada
      • 11.1.2.1 Market Trends
      • 11.1.2.2 Market Forecast
  • 11.2 Asia Pacific
    • 11.2.1 China
      • 11.2.1.1 Market Trends
      • 11.2.1.2 Market Forecast
    • 11.2.2 Japan
      • 11.2.2.1 Market Trends
      • 11.2.2.2 Market Forecast
    • 11.2.3 India
      • 11.2.3.1 Market Trends
      • 11.2.3.2 Market Forecast
    • 11.2.4 South Korea
      • 11.2.4.1 Market Trends
      • 11.2.4.2 Market Forecast
    • 11.2.5 Australia
      • 11.2.5.1 Market Trends
      • 11.2.5.2 Market Forecast
    • 11.2.6 Indonesia
      • 11.2.6.1 Market Trends
      • 11.2.6.2 Market Forecast
    • 11.2.7 Others
      • 11.2.7.1 Market Trends
      • 11.2.7.2 Market Forecast
  • 11.3 Europe
    • 11.3.1 Germany
      • 11.3.1.1 Market Trends
      • 11.3.1.2 Market Forecast
    • 11.3.2 France
      • 11.3.2.1 Market Trends
      • 11.3.2.2 Market Forecast
    • 11.3.3 United Kingdom
      • 11.3.3.1 Market Trends
      • 11.3.3.2 Market Forecast
    • 11.3.4 Italy
      • 11.3.4.1 Market Trends
      • 11.3.4.2 Market Forecast
    • 11.3.5 Spain
      • 11.3.5.1 Market Trends
      • 11.3.5.2 Market Forecast
    • 11.3.6 Russia
      • 11.3.6.1 Market Trends
      • 11.3.6.2 Market Forecast
    • 11.3.7 Others
      • 11.3.7.1 Market Trends
      • 11.3.7.2 Market Forecast
  • 11.4 Latin America
    • 11.4.1 Brazil
      • 11.4.1.1 Market Trends
      • 11.4.1.2 Market Forecast
    • 11.4.2 Mexico
      • 11.4.2.1 Market Trends
      • 11.4.2.2 Market Forecast
    • 11.4.3 Others
      • 11.4.3.1 Market Trends
      • 11.4.3.2 Market Forecast
  • 11.5 Middle East and Africa
    • 11.5.1 Market Trends
    • 11.5.2 Market Breakup by Country
    • 11.5.3 Market Forecast

12 SWOT Analysis

  • 12.1 Overview
  • 12.2 Strengths
  • 12.3 Weaknesses
  • 12.4 Opportunities
  • 12.5 Threats

13 Value Chain Analysis

14 Porters Five Forces Analysis

  • 14.1 Overview
  • 14.2 Bargaining Power of Buyers
  • 14.3 Bargaining Power of Suppliers
  • 14.4 Degree of Competition
  • 14.5 Threat of New Entrants
  • 14.6 Threat of Substitutes

15 Competitive Landscape

  • 15.1 Market Structure
  • 15.2 Key Players
  • 15.3 Profiles of Key Players
    • 15.3.1 Abbott Laboratories
      • 15.3.1.1 Company Overview
      • 15.3.1.2 Product Portfolio
      • 15.3.1.3 Financials
      • 15.3.1.4 SWOT Analysis
    • 15.3.2 Danaher Corporation
      • 15.3.2.1 Company Overview
      • 15.3.2.2 Product Portfolio
      • 15.3.2.3 SWOT Analysis
    • 15.3.3 Becton, Dickinson and Company
      • 15.3.3.1 Company Overview
      • 15.3.3.2 Product Portfolio
      • 15.3.3.3 Financials
      • 15.3.3.4 SWOT Analysis
    • 15.3.4 bioMeriux SA
      • 15.3.4.1 Company Overview
      • 15.3.4.2 Product Portfolio
    • 15.3.5 Bruker Corporation
      • 15.3.5.1 Company Overview
      • 15.3.5.2 Product Portfolio
      • 15.3.5.3 Financials
      • 15.3.5.4 SWOT Analy
    • 15.3.6 Luminex Corporation
      • 15.3.6.1 Company Overview
      • 15.3.6.2 Product Portfolio
      • 15.3.6.3 Financials
      • 15.3.6.4 SWOT Analysis
    • 15.3.7 Merck KGaA
      • 15.3.7.1 Company Overview
      • 15.3.7.2 Product Portfolio
      • 15.3.7.3 Financials
      • 15.3.7.4 SWOT Analysis
    • 15.3.8 Siemens Healthcare GmbH
      • 15.3.8.1 Company Overview
      • 15.3.8.2 Product Portfolio
    • 15.3.9 F.Hoffmann-La Roche Ltd
      • 15.3.9.1 Company Overview
      • 15.3.9.2 Product Portfolio
    • 15.3.10 T2 Biosystems Inc
      • 15.3.10.1 Company Overview
      • 15.3.10.2 Product Portfolio
    • 15.3.11 Thermo Fisher Scientific Company
      • 15.3.11.1 Company Overview
      • 15.3.11.2 Product Portfolio
      • 15.3.11.3 Financials
      • 15.3.11.4 SWOT Analysis

List of Figures

  • Figure 1: Global: Blood Culture Test Market: Major Drivers and Challenges
  • Figure 2: Global: Blood Culture Test Market: Sales Value (in Billion US$), 2018-2023
  • Figure 3: Global: Blood Culture Test Market: Breakup by Testing Method (in %), 2023
  • Figure 4: Global: Blood Culture Test Market: Breakup by Product (in %), 2023
  • Figure 5: Global: Blood Culture Test Market: Breakup by Technology (in %), 2023
  • Figure 6: Global: Blood Culture Test Market: Breakup by Application (in %), 2023
  • Figure 7: Global: Blood Culture Test Market: Breakup by End-User (in %), 2023
  • Figure 8: Global: Blood Culture Test Market: Breakup by Region (in %), 2023
  • Figure 9: Global: Blood Culture Test Market Forecast: Sales Value (in Billion US$), 2024-2032
  • Figure 10: Global: Blood Culture Test (Conventional Testing) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 11: Global: Blood Culture Test (Conventional Testing) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 12: Global: Blood Culture Test (Automated Testing) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 13: Global: Blood Culture Test (Automated Testing) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 14: Global: Blood Culture Test (Consumables) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 15: Global: Blood Culture Test (Consumables) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 16: Global: Blood Culture Test (Instruments) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 17: Global: Blood Culture Test (Instruments) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 18: Global: Blood Culture Test (Software and Services) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 19: Global: Blood Culture Test (Software and Services) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 20: Global: Blood Culture Test (Culture-based Technology) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 21: Global: Blood Culture Test (Culture-based Technology) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 22: Global: Blood Culture Test (Molecular Technology) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 23: Global: Blood Culture Test (Molecular Technology) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 24: Global: Blood Culture Test (Proteomic Technology) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 25: Global: Blood Culture Test (Proteomic Technology) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 26: Global: Blood Culture Test (Others) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 27: Global: Blood Culture Test (Others) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 28: Global: Blood Culture Test (Bacterial Infections) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 29: Global: Blood Culture Test (Bacterial Infections) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 30: Global: Blood Culture Test (Fungal Infections) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 31: Global: Blood Culture Test (Fungal Infections) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 32: Global: Blood Culture Test (Mycobacterial Infections) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 33: Global: Blood Culture Test (Mycobacterial Infections) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 34: Global: Blood Culture Test (Hospital Laboratories) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 35: Global: Blood Culture Test (Hospital Laboratories) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 36: Global: Blood Culture Test (Reference Laboratories) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 37: Global: Blood Culture Test (Reference Laboratories) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 38: Global: Blood Culture Test (Research Laboratories) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 39: Global: Blood Culture Test (Research Laboratories) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 40: Global: Blood Culture Test (Other End-Users) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 41: Global: Blood Culture Test (Other End-Users) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 42: North America: Blood Culture Test Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 43: North America: Blood Culture Test Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 44: United States: Blood Culture Test Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 45: United States: Blood Culture Test Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 46: Canada: Blood Culture Test Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 47: Canada: Blood Culture Test Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 48: Asia Pacific: Blood Culture Test Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 49: Asia Pacific: Blood Culture Test Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 50: China: Blood Culture Test Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 51: China: Blood Culture Test Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 52: Japan: Blood Culture Test Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 53: Japan: Blood Culture Test Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 54: India: Blood Culture Test Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 55: India: Blood Culture Test Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 56: South Korea: Blood Culture Test Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 57: South Korea: Blood Culture Test Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 58: Australia: Blood Culture Test Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 59: Australia: Blood Culture Test Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 60: Indonesia: Blood Culture Test Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 61: Indonesia: Blood Culture Test Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 62: Others: Blood Culture Test Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 63: Others: Blood Culture Test Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 64: Europe: Blood Culture Test Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 65: Europe: Blood Culture Test Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 66: Germany: Blood Culture Test Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 67: Germany: Blood Culture Test Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 68: France: Blood Culture Test Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 69: France: Blood Culture Test Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 70: United Kingdom: Blood Culture Test Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 71: United Kingdom: Blood Culture Test Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 72: Italy: Blood Culture Test Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 73: Italy: Blood Culture Test Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 74: Spain: Blood Culture Test Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 75: Spain: Blood Culture Test Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 76: Russia: Blood Culture Test Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 77: Russia: Blood Culture Test Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 78: Others: Blood Culture Test Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 79: Others: Blood Culture Test Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 80: Latin America: Blood Culture Test Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 81: Latin America: Blood Culture Test Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 82: Brazil: Blood Culture Test Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 83: Brazil: Blood Culture Test Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 84: Mexico: Blood Culture Test Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 85: Mexico: Blood Culture Test Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 86: Others: Blood Culture Test Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 87: Others: Blood Culture Test Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 88: Middle East and Africa: Blood Culture Test Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 89: Middle East and Africa: Blood Culture Test Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 90: Global: Blood Culture Test Industry: SWOT Analysis
  • Figure 91: Global: Blood Culture Test Industry: Value Chain Analysis
  • Figure 92: Global: Blood Culture Test Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Blood Culture Test Market: Key Industry Highlights, 2023 and 2032
  • Table 2: Global: Blood Culture Test Market Forecast: Breakup by Testing Method (in Million US$), 2024-2032
  • Table 3: Global: Blood Culture Test Market Forecast: Breakup by Product (in Million US$), 2024-2032
  • Table 4: Global: Blood Culture Test Market Forecast: Breakup by Technology (in Million US$), 2024-2032
  • Table 5: Global: Blood Culture Test Market Forecast: Breakup by Application (in Million US$), 2024-2032
  • Table 6: Global: Blood Culture Test Market Forecast: Breakup by End-User (in Million US$), 2024-2032
  • Table 7: Global: Blood Culture Test Market Forecast: Breakup by Region (in Million US$), 2024-2032
  • Table 8: Global: Blood Culture Test Market: Competitive Structure
  • Table 9: Global: Blood Culture Test Market: Key Players